Intuitive Surgical Inc. (NASDAQ:ISRG) shares are trending on Friday.
Shares of the California-based medical technology and robotics company edged 0.14% higher to $375 after the bell on Thursday.
In the regular session, ISRG closed at $374.48, down 5.84%, according to Benzinga Pro data.
The stock saw slightly higher-than-average trading activity on Thursday, with 3.97 million shares traded compared with an average volume of 3.70 million.
Intuitive Surgical is known for developing and manufacturing the da Vinci Surgical System, a pioneering robotic-assisted platform used to perform complex, minimally invasive procedures.
Insider Sale
The stock move came after a Thursday Securities and Exchange Commission filing showed that Executive Vice President and Chief Manufacturing and Supply Chain Officer Mark Brosius sold 77 shares each on Monday, Tuesday and Wednesday, at prices ranging from $390.67 to $394.26.
The three-day sale totaled 231 shares worth approximately $90,777.
The sales were executed under a pre-arranged trading plan for insider transactions that is set to expire Feb. 14, 2027.
Malaysia Expansion
The stock move also follows Intuitive’s Monday announcement that it signed a lease agreement with Penang Development Corporation for a new 316,000-square-foot manufacturing facility in Penang, Malaysia.
The site is expected to begin operations in 2028 and create 1,200 jobs by 2032, manufacturing surgical instruments and electromechanical devices for the company’s da Vinci surgical system.
Glenn Vavoso, Senior Vice President and President of Asia Pacific, Intuitive, said, “Asia Pacific represents one of the most exciting growth opportunities for robotic-assisted surgery,” adding that the move strengthens the company’s ability to expand patient access in the region.
Trading Metrics, Technical Analysis
Intuitive Surgical has a market capitalization of $132.30 billion, a 52-week high of $603.88 and a 52-week low of $328.57.
The Relative Strength Index (RSI) of ISRG stands at 45.40.
The small-cap stock has fallen 20.30% over the past 12 months.
ISRG is currently trading near the lower end of its 52-week range.
In August, Oppenheimer (NYSE:OPY) analyst Suraj Kalia upgraded the stock from Perform to Outperform, setting a $500 price target.
Benzinga’s Edge Stock Rankings indicate that ISRG is experiencing short-term upward movement along with medium and long-term consolidation.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo: michelmond / Shutterstock
Recent Comments